We can actually support and nudge increase of GLP-1 (Glucagon-like peptide-1) naturally, which is the very hormone these medications mimic, through targeted, evidence-based nutritional strategies
Patients should report suspected side effects to their healthcare professional or via the MHRA Yellow Card scheme
In addition to effective and sustained weight loss, many patients experience improved health markers, including lower blood sugar levels, better blood pressure, and healthier cholesterol numbers
Genetically predicted glucose-dependent insulinotropic polypeptide (GIP) levels and cardiovascular disease risk are driven by distinct causal variants in the GIPR region
It has been shown that in patients with type 2 diabetes mellitus (T2DM) the response to the incretin effect is altered as a result of a severe defect in the sensitivity for GIP in the cells [4] and a reduction in food-induced GLP-1 secretion [5, 6]
They are not a substitute for prescription GLP-1 medications and are intended to complement a balanced lifestyle